Challenges of securing insurance approval for oral tofacitinib for the treatment of alopecia areata: a multi-institution retrospective review
Sign Up to like & getrecommendations! Published in 2021 at "Archives of Dermatological Research"
DOI: 10.1007/s00403-020-02158-y
Abstract: Alopecia areata (AA) is a psychologically distressing disorder for which few reliable treatments exist. Although oral tofacitinib has demonstrated efficacy in treating AA, it is not approved by the Food and Drug Administration (FDA) for… read more here.
Keywords: oral tofacitinib; tofacitinib; insurance approval; approval ... See more keywords
Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the American Academy of Dermatology"
DOI: 10.1016/j.jaad.2016.11.038
Abstract: SALT, Severity of Alopecia Tool. To the Editor: Alopecia areata, especially alopecia universalis, can be challenging to treat in children and adolescents. Standard therapies, including oral, topical, and intralesional corticosteroids, usually fail or have high… read more here.
Keywords: oral tofacitinib; tofacitinib; experience oral; alopecia universalis ... See more keywords
Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2018.1466024
Abstract: Abstract Background: A few anecdotal case reports demonstrated that tofacitinib improved nail changes associated with AA. Objective: To investigate nail changes in patients with AA treated with tofacitinib and evaluate the relationship between nail and… read more here.
Keywords: oral tofacitinib; nail involvement; hair; patients moderate ... See more keywords
Efficacy of oral tofacitinib in refractory chronic spontaneous urticaria and urticarial vasculitis
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Therapy"
DOI: 10.1111/dth.15932
Abstract: The treatment of chronic urticaria (CU) is difficult, currently, antihistamines (AH) are the mainstay of treatment, however, up to 40% of patients do not respond to even high (four‐fold) daily doses of AH. Tofacitinib is,… read more here.
Keywords: tofacitinib refractory; vasculitis; efficacy oral; oral tofacitinib ... See more keywords
Treatment outcome of oral tofacitinib and ruxolitinib in patients with alopecia areata: A systematic review and meta-analysis.
Sign Up to like & getrecommendations! Published in 2021 at "Indian journal of dermatology, venereology and leprology"
DOI: 10.25259/ijdvl_975_19
Abstract: BACKGROUND Tofacitinib and ruxolitinib have been used off-label to treat alopecia areata. Although a number of case reports and small studies have been published, there are no comprehensive reviews examining the outcomes of using tofacitinib… read more here.
Keywords: oral tofacitinib; treatment; ruxolitinib; alopecia areata ... See more keywords
Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.891434
Abstract: Introduction Alopecia areata (AA) is an autoimmune hair loss mediated by CD8 + T cells. Treatment for moderate-to-severe AA is still challenging. Janus kinase inhibitors, such as tofacitinib, have been recently investigated as a promising… read more here.
Keywords: combination; oral tofacitinib; group; moderate severe ... See more keywords